Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
about
Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.Primary progressive aphasia: a clinical approach.Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.A Longitudinal Study of a Chinese Man Presenting with Non-Fluent/Agrammatic Variant of Primary Progressive Aphasia.
P2860
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
@en
type
label
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
@en
prefLabel
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
@en
P2093
P2860
P1433
P1476
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
@en
P2093
Corey T McMillan
David A Wolk
David J Irwin
Edward B Lee
Katya Rascovsky
Lucia A A Giannini
Sharon Ash
Vivianna M Van Deerlin
P2860
P304
P356
10.1212/WNL.0000000000004034
P407
P577
2017-05-17T00:00:00Z